3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
Feature | Mark Michael, M.D., and Jeffrey A. Breall, M.D., Ph.D.
Management of coronary chronic total occlusion (CTO) is individualized depending on the severity of symptoms, ischemia ...
March 19, 2012
Feature | Mark Paquin
April 15, 2012, will mark the 10th anniversary of the approval of the first drug-eluting stent (DES). Ten years ago, the ...
March 16, 2012
March 15, 2012 — According to Millennium Research Group (MRG) the interventional cardiology (IC) market in Pakistan ...
March 15, 2012
Feature | Vascular Closure Devices| Dave Fornell
Manual compression remains the gold standard of care in sealing interventional access site wounds, but there is a trend ...
February 01, 2012
December 22, 2011 – Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe ...
December 22, 2011
December 9, 2011 — Abbott announced Thursday the initiation of ABSORB II, the first randomized, controlled, multi-center ...
December 09, 2011
November 15, 2011 – Abbott announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ...
November 15, 2011
November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real ...
November 14, 2011
MitraClip Offers Significant Improvements for Both Functional, Degenerative MR in High-Risk Patients
November 10, 2011 — The results of an analysis of 149 EVEREST II high surgical risk patients with significant mitral ...
November 10, 2011
November 8, 2011 – Abiomed, a provider of heart support technologies, announced results of an economic study at the ...
November 08, 2011